Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study (2017)
- Authors:
- Callefi, Luciana Azevêdo
- Villela-Nogueira, Cristiane Alves
- Tenore, Simone de Barros
- Carnaúba-Júnior, Dimas
- Coelho, Henrique Sérgio Moraes
- Pinto, Paulo de Tarso A.
- Nabuco, Letícia Cancella
- Pessôa, Mário Guimarães
- Ferraz, Maria Lúcia Cardoso Gomes
- Ferreira, Paulo Roberto Abrão
- Martinelli, Ana de Lourdes Candolo
- Chachá, Silvana Gama Florencio
- Ferreira, Adalgisa de Souza Paiva
- Bisio, Alessandra Porto de Macedo
- Brandão-Mello, Carlos Eduardo
- Álvares-da-Silva, Mário Reis
- Reuter, Tania
- Ivantes, Claudia Alexandra Pontes
- Perez, Renata de Mello
- Mendes-Côrrea, Maria Cássia Jacintho
- Autor USP: MARTINELLI, ANA DE LOURDES CANDOLO - FMRP
- Unidade: FMRP
- DOI: 10.6061/clinics/2017(06)08
- Subjects: INIBIDORES DE ENZIMAS; HEPATITE C; DOENÇA CRÔNICA; ESTUDOS MULTICÊNTRICOS
- Keywords: Protease inhibitors; Safety; Hepatitis C; Chronic; Therapeutics
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CALLEFI, Luciana Azevêdo et al. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics, v. 72, n. 6, p. 378-385, 2017Tradução . . Disponível em: https://doi.org/10.6061/clinics/2017(06)08. Acesso em: 27 jan. 2026. -
APA
Callefi, L. A., Villela-Nogueira, C. A., Tenore, S. de B., Carnaúba-Júnior, D., Coelho, H. S. M., Pinto, P. de T. A., et al. (2017). Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics, 72( 6), 378-385. doi:10.6061/clinics/2017(06)08 -
NLM
Callefi LA, Villela-Nogueira CA, Tenore S de B, Carnaúba-Júnior D, Coelho HSM, Pinto P de TA, Nabuco LC, Pessôa MG, Ferraz MLCG, Ferreira PRA, Martinelli A de LC, Chachá SGF, Ferreira A de SP, Bisio AP de M, Brandão-Mello CE, Álvares-da-Silva MR, Reuter T, Ivantes CAP, Perez R de M, Mendes-Côrrea MCJ. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study [Internet]. Clinics. 2017 ; 72( 6): 378-385.[citado 2026 jan. 27 ] Available from: https://doi.org/10.6061/clinics/2017(06)08 -
Vancouver
Callefi LA, Villela-Nogueira CA, Tenore S de B, Carnaúba-Júnior D, Coelho HSM, Pinto P de TA, Nabuco LC, Pessôa MG, Ferraz MLCG, Ferreira PRA, Martinelli A de LC, Chachá SGF, Ferreira A de SP, Bisio AP de M, Brandão-Mello CE, Álvares-da-Silva MR, Reuter T, Ivantes CAP, Perez R de M, Mendes-Côrrea MCJ. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study [Internet]. Clinics. 2017 ; 72( 6): 378-385.[citado 2026 jan. 27 ] Available from: https://doi.org/10.6061/clinics/2017(06)08 - Correlation between the levels of hcv in serem and liver of patientes with chronic hepatites
- Hipertensão portal
- Síndrome hepatopulmonar: Patogenia, diagnóstico e tratamento
- Icterícia
- Hepatitis c: five years
- New direct action antivirals containing regimes to treat patients with hepatitis C chronic infection: first results from a national real-world registry of the Brazilian Hepatology Society
- Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies
- Quantitative assesment of hepatitis c virus (cv) rna and hcv care igm antibodies
- Relationship between genotype and viral load in chronic hepatitis c virus infection
- Prospective evaluation of Peginterferon alfa-2A (40KD)-Ribavirin in CHC, IFN/Ribavirin nonresponders/relapsers
Informações sobre o DOI: 10.6061/clinics/2017(06)08 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002917067.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
